Accord have told us that they have an expected re-supply date for Accord levetiracetam 250mg, 500mg and 750mg tablets of October 2025.

Two national NHS trials will investigate safety and effectiveness of cannabidiol (CBD) and tetrahydrocannabinol (THC) in refractory epilepsy.

A ‘brain pacemaker’ aiming to reduce seizures in people with drug-resistant focal epilepsy is now available on the NHS.

NICE has published its updated guidelines on menopause today, but Epilepsy Action warns that epilepsy has been left behind in the guidance.

Experts at the University of Queensland have developed medicine based on spider venom which could help treat some forms of genetic epilepsy.

A new fibre-optic laser therapy for people with drug-resistant focal epilepsy will be offered on the NHS, with the first of these surgeries taking place in early 2023. This new technology allows ...

A new US study finds link between gabapentin use in people with chronic nerve pain and a higher risk of dementia.

Epilepsy Action is the only epilepsy charity with PIF TICK accreditation for its information Epilepsy Action has been awarded PIF TICK accreditation for a further year. The certification recognises ...

Claudia now wants to share her experience about both epilepsy and autism to help others who may be going through similar experiences, and raise awareness of how epilepsy and autism can collide to get ...

A new, seven-year project from the University of Liverpool will investigate the long-term effectiveness of VNS in refractory epilepsy.

A major milestone in epilepsy care has been reached in the UK. The first patient has received the EASEE® implant at the Royal Victoria Infirmary in Newcastle. This new treatment is now available on ...

Epilepsy Action is opposing proposed changes to Personal Independent Payments (PIP) announced this week by the UK government. The Department for Work and Pensions announced a consultation into the ...